Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q2 FY20 results · Jul–Sep 2019
Wockhardt reported revenue from operations of ₹802.18 crore (down 28.7% from Q2 FY19) and net loss of ₹94.24 crore for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 802.18 | 1,125.68 | −28.7% | 863.11 | −7.1% |
| Other income | (0.20) | 6.09 | Turned loss | 8.08 | Turned loss |
| Total income | 801.98 | 1,131.77 | −29.1% | 871.19 | −7.9% |
| Profit before tax | (70.55) | (31.79) | Loss widened | (77.86) | Loss narrowed |
| Net profit for the period | (94.24) | (30.84) | Loss widened | (36.88) | Loss widened |
| Attributable to shareholders of the company | (82.17) | — | — | — | — |
| EPS, basic (₹) | (7.42) | (2.06) | Loss widened | (4.06) | Loss widened |
| Net margin (%) | -11.7 | -2.7 | -4.3 |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 424.28 | 634.59 | −33.1% | 352.21 | +20.5% |
| Other income | 2.01 | 8.38 | −76.0% | 8.61 | −76.7% |
| Total income | 426.29 | 642.97 | −33.7% | 360.82 | +18.1% |
| Profit before tax | 1.48 | 8.58 | −82.8% | (133.18) | Turned profit |
| Net profit for the period | 0.07 | 5.10 | −98.6% | (82.93) | Turned profit |
| EPS, basic (₹) | 0.01 | 0.46 | −97.8% | (7.49) | Turned profit |
| Net margin (%) | 0.0 | 0.8 | -23.5 |
Consolidated
- Filed with BSE
- 07 Nov 2019, 18:25 IST
- Board meeting
- 07 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2019, 18:25 IST
- Board meeting
- 07 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE